Order Article Reprints

Dallons M, Alpan E, Schepkens C, Tagliatti V, Colet J-M. GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells. Cells. 2020; 9(10):2177. https://doi.org/10.3390/cells9102177

Dallons, Matthieu, Esma Alpan, Corentin Schepkens, Vanessa Tagliatti, and Jean-Marie Colet. 2020. "GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells" Cells 9, no. 10: 2177. https://doi.org/10.3390/cells9102177

Dallons, M., Alpan, E., Schepkens, C., Tagliatti, V., & Colet, J. -M. (2020). GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells. Cells, 9(10), 2177. https://doi.org/10.3390/cells9102177